Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Joseph Edelman’

Countries with the Smallest Government Per Capita in the World

Hedge Fund and Insider Trading News: Eddie Lampert, Elliott Management, AT&T Inc. (T), Estee Lauder Companies Inc (EL), and More

U.S. Federal Pension Insurer Backs Eddie Lampert’s Bid to Buy Sears (The Wall Street Journal) Sears Holdings Corp. Chairman Eddie Lampert won the support......(read more)
Insider Trading Back

Hedge Fund and Insider Trading News: Brevan Howard Asset Management, Joseph Edelman, Workday, Inc. (WDAY), Goodrich Petroleum Co. (GDP), Evans & Sutherland (ESCC), and More

Brevan Howard Plans Asia Macro Fund Run by Trader Bathwal (Bloomberg) Brevan Howard Asset Management is raising money for a new macro hedge fund managed......(read more)
Insider Trading, NYSE, Markets, Stock Trader On The Phone

Hedge Fund and Insider Trading News: Joseph Edelman, Accipiter Capital, EntreMed, Inc. (CASI), WideOpenWest Inc (WOW), National CineMedia, Inc. (NCMI), and More

3 Biotech Stocks a Pro Is Buying Now (Barron’s) The last time we checked in with Joseph Edelman, the founder, chief executive and portfolio manager......(read more)
Countries with Highest Natural Gas Reserves

Big Insider Buying at Hot IPO Solid Biosciences (SLDB), Range Resources (RRC) and General Electric (GE)

With the stock market having been battered in recent days and fears that a large correction may be starting to pick up steam becoming more pronounced,......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Big Bet on Sarepta Therapeutics Inc (SRPT) Lifts Perceptive Advisors’ Q3 Returns; See How Other Investments Performed

Joseph Edelman‘s Perceptive Advisors is a fund that has an equity portfolio worth $1.44 billion as of the end of June, with over 80% of it being......(read more)
Clint Carlson of Carlson Capital

Hedge Funds Reveal Latest Moves; Which Ones Should You Follow?

With the latest round of 13F filings gathering pace, hedge fund managers are busy preparing to deluge us with the contents of their portfolios, which......(read more)
Amicus Therapeutics

Amicus Therapeutics, Inc. (FOLD), Neurocrine Biosciences, Inc. (NBIX), and Retrophin Inc (RTRX) among Biotech Guru Joseph Edelman’s Top Healthcare Picks

Biotech Guru Joseph Edelman‘s Perceptive Advisors is known for its long-short investment approach that focuses on biotech stocks. Edelman founded......(read more)
Sergey Nivens/shutterstock.com

More Than 60% Returns For These Two Hedgies’ Favorite Health Care Picks

The health care sector has appreciated by nearly 30% over the past year. We decided to take a look at three companies that two health care-focused funds......(read more)
Andreas Halvorsen

Kansas City Southern (KSU), Cheniere Energy Inc. (LNG), Xencor Inc (XNCR): Viking Global Continues to Bet Big; Adage Capital Increase its Stake

Andreas Halvorsen’s Viking Global recently increased its exposure to Kansas City Southern (NYSE:KSU) by 1.3 million shares. According to the 13G Form......(read more)
Roberto-Mignone1

Arrowhead Research Corp (ARWR): Bridger Management Builds 5.5% Passive Stake

Roberto Mignone’s Bridger Management has amassed a 5.5% stake in Arrowhead Research Corp (NASDAQ:ARWR) according to a 13G filing with the Securities......(read more)
Amicus Therapeutics

Amicus Therapeutics, Inc. (FOLD): Redmile Group Trims Position and Books Some Profits from Long-Term Investment

Jeremy Green‘s Redmile Group has also reduced its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD), after yesterday, William Leland Edwards’......(read more)
StemCells Inc (NASDAQ:STEM)

Hal Mintz And Sabby Capital Disclose New Investments In StemCells Inc (STEM) And Skystar Bio-Pharmaceutical Company (SKBI)

Hal Mintz, the manager of Sabby Capital, believes StemCells Inc (NASDAQ:STEM) is a good investment and has opened a position for his fund. According......(read more)
Aerie Pharmaceuticals

Deerfield Management Ups Stake in Aerie Pharmaceuticals Inc (AERI)

In a new filing with the Securities and Exchange Commission, James E. Flynn of Deerfield Management, has revealed a 6.05% stake in Aerie Pharmaceuticals......(read more)
Amicus Therapeutics

Perceptive Advisors Buys 4.0 Million Shares Of Amicus Therapeutics Inc. (FOLD)

Perceptive Advisors, managed by Joseph Edelman, is bullish on Amicus Therapeutics Inc. (NASDAQ:FOLD). In a new filing with the U.S. Securities and Exchange......(read more)
insider trading

5 Stocks Insiders are Buying Right Now

According to our research, stocks bought by insiders demonstrate a small outperformance effect, which seems logical given the fact that insiders are the......(read more)
PAULSON & CO

Top 20 Hedge Funds with Highest Returns

HSBC Hedge Weekly, in its issue Nr. 48, has published a list of the best hedge fund returns. Out of the issue, we have selected the list with top 20......(read more)
AcelRx Pharmaceuticals Inc

Why Is Joseph Edelman’s Hedge Fund So Bullish On AcelRx?

In a disclosure of its holdings, Joseph Edelman’s Perceptive Advisors made public that it currently owns 6.57 million shares of AcelRx Pharmaceuticals......(read more)
AcelRx Pharmaceuticals Inc

Joseph Edelman, Perceptive Advisors Continue Bullish Streak in AcelRX Pharmaceuticals

Joseph Edelman’s fund Perceptive Advisors continues its bullish streak on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) disclosing increasing its position......(read more)
AcelRx Pharmaceuticals Inc

Joseph Edelman’s Perceptive Advisors Buys More AcelRx Pharmaceuticals

Joseph Edelman‘s fund, Perceptive Advisors, in a new filing reported increasing its position in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) again,......(read more)
AcelRx Pharmaceuticals Inc

Joseph Edelman and Perceptive Advisors Buy 360,700 Shares of AcelRx Pharmaceuticals

Hedge fund Perceptive Advisors, founded and managed by Joseph Edelman, increased its position in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) by some 360......(read more)
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX)

Hedge Funds Are Crazy About Astex Pharmaceuticals, Inc. (ASTX)

What’s a smart Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) investor to do? In the 21st century investor’s toolkit, there are dozens of indicators......(read more)
Dyax Corp. (NASDAQ:DYAX)

Dyax Corp. (DYAX): Are Hedge Funds Right About This Stock?

Is it smart to be bullish on Dyax Corp. (NASDAQ:DYAX)? Now, according to many of your fellow readers, hedge funds are viewed as delayed, old investment......(read more)
Capital Senior Living Corporation

This Metric Says You Are Smart to Sell Capital Senior Living Corporation (CSU)

To the average investor, there are dozens of methods investors can use to track publicly traded companies. Two of the best are hedge fund and insider......(read more)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)

Is it smart to be bullish on Neurocrine Biosciences, Inc. (NASDAQ:NBIX)? In the financial world, there are dozens of indicators investors can use to......(read more)
Santarus, Inc. (NASDAQ:SNTS)

Santarus, Inc. (SNTS): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

What should a smart Santarus, Inc. (NASDAQ:SNTS) investor do? In the financial world, there are a multitude of gauges investors can use to watch publicly......(read more)
Sarepta Therapeutics Inc

Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)

Is it smart to be bullish on Sarepta Therapeutics Inc (NASDAQ:SRPT)? If you were to ask many of your fellow readers, hedge funds are seen as overrated......(read more)
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)

NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

In today’s marketplace, there are tons of gauges market participants can use to track their holdings. A duo of the most innovative are hedge fund and......(read more)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)

Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?

To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies. Some of the most under-the-radar are......(read more)
Synta Pharmaceuticals Corp. (NASDAQ:SNTA)

Why Synta Pharmaceuticals Corp. (SNTA) May Be Worth Selling

If you’re a Synta Pharmaceuticals Corp. (NASDAQ:SNTA) investor, this data will make you want to rethink your position. Just sayin’. If you......(read more)
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Alnylam Pharmaceuticals, Inc. (ALNY): Here’s What The Smart Money Thinks

Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view. The number of bullish......(read more)
MILLENNIUM MANAGEMENT

Is Supernus Pharmaceuticals Inc (SUPN) Going to Burn These Hedge Funds?

Supernus Pharmaceuticals Inc (NASDAQ:SUPN) investors should be aware of a decrease in enthusiasm from smart money in recent months. To most shareholders......(read more)

AcelRx Pharmaceuticals Inc (ACRX): Insiders Are Buying, Should You?

Is AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) a first-rate investment today? Hedge funds are getting less optimistic. The number of long hedge fund bets......(read more)
Pacific Biosciences of California (NASDAQ:PACB)

Is Pacific Biosciences of California (PACB) Going to Burn These Hedge Funds?

Pacific Biosciences of California (NASDAQ:PACB) was in 7 hedge funds’ portfolio at the end of the first quarter of 2013. PACB investors should be......(read more)
Uroplasty, Inc. (NASDAQ:UPI)

Here is What Hedge Funds Think About Uroplasty, Inc. (UPI)

Uroplasty, Inc. (NASDAQ:UPI) has experienced a decrease in support from the world’s most elite money managers recently. In today’s marketplace......(read more)
RENAISSANCE TECHNOLOGIES

The Terrible 20: Underperforming Stocks with High Short Interest

The list of the stocks with a high level of short interest is filled with many names investors should expect, while others may come as a surprise. The......(read more)